Dexamethasone Treatment Options

A collection of 1460 research studies where Dexamethasone is the interventional treatment. These studies are located in the United States . Dexamethasone is used for conditions such as Multiple Myeloma, Postoperative Pain and Lymphoma.

Home

All Treatments

Dexamethasone

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Offer

Lose Weight with GLP-1 Medications

Recruiting

Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.

As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients

NCT05546359

Completed

Randomized, double-blind, pediatric trial of amisulpride for prophylaxis of post operative nausea and vomiting

Gender:

ALL

Ages:

Between 2 months and 17 years

Trial Updated:

06/20/2025

Locations: Helen Keller Hospital, Sheffield, Alabama +13 locations

Conditions: Nausea and Vomiting, Postoperative

Learn More ›

A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias

NCT05521087

Withdrawn

The purpose of this study is to determine the recommended Phase 2 dose(s) (RP2Ds) of JNJ-75276617 in combination with a conventional chemotherapy backbone in pediatric and young adult participants with relapsed/refractory acute leukemia harboring histone-lysine N-methyltransferase 2A1 (\[KMT2A1\], nucleophosmin 1 gene (NPM1), or nucleoporin alterations in Part 1 (Dose Escalation) and to further evaluate safety at the RP2D(s) of JNJ-75276617 in combination with chemotherapy in pediatric and young... Read More

Gender:

ALL

Ages:

Between 30 days and 30 years

Trial Updated:

06/20/2025

Locations: University of Alabama at Birmingham, Birmingham, Alabama +10 locations

Conditions: Acute Leukemias, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Leukemia of Ambiguous Lineage

Learn More ›

Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM

NCT06974604

Not Yet Recruiting

TROPION-DM/BrUOG-431 is a prospective, , phase 2 trial with two non-comparative cohorts analyzed jointly for primary endpoint in adult patients with either (Cohort 1:) advanced/metastatic hormone-receptor positive (\[HR+\], estrogen receptor and/or progesterone receptor positive) breast cancer (BC), or advanced/metastatic triple negative breast cancer (TNBC) or (Cohort 2:) advanced/metastatic non-squamous non-small cell lung cancer (NSCLC). All patients will be treated with Datopotumab deruxtec... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/19/2025

Locations: Rhode Island and the Miriam Hospitals (Brown University Health), Providence, Rhode Island

Conditions: Breast Neoplasms, Lung Neoplasms

Learn More ›

Phase I/II Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Myeloid Malignancies

NCT06383572

Recruiting

To find a recommended dose of PRAME-TCR-NK cells that can be given to patients with AML or MDS.

Gender:

ALL

Ages:

Between 18 years and 80 years

Trial Updated:

06/19/2025

Locations: MD Anderson Cancer Center, Houston, Texas

Conditions: Lymphodepleting Chemotherapy, Myeloid Malignancies

Learn More ›

Dexamethasone, Elotuzumab, and Pomalidomide in Treating Patients With Refractory Multiple Myeloma

NCT03713294

Completed

This phase II trial studies how well dexamethasone, elotuzumab, pomalidomide work in treating patients with multiple myeloma that has not responded to previous treatment. Drugs used in chemotherapy, such as dexamethasone, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as elotuzumab, may help the body's immune system attack the cancer, and may... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/19/2025

Locations: Mayo Clinic in Florida, Jacksonville, Florida

Conditions: Refractory Plasma Cell Myeloma

Learn More ›

Safety and Efficacy of a Drug Eluting Slim Modiolar Electrode Array

NCT06598059

Recruiting

This clinical study will test a new type of cochlear implant known as CI632D. This experimental cochlear implant has been designed to slowly release a drug called dexamethasone. Dexamethasone works to ease inflammation and reduce tissue injury, which is common after any type of surgery. The goal is to learn if the dexamethasone in the CI632D implant lessens these reactions inside the ear following surgery and if this makes the implant work as well, or even better, in improving hearing than what... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/18/2025

Locations: UCLA Medical Center, Los Angeles, California +10 locations

Conditions: Hearing Loss

Learn More ›

A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.

NCT03539744

Active Not Recruiting

A study designed tocompare progression-free survival (PFS) in participants with t(11;14)-positive MM treated with venetoclax in combination with dexamethasone versus pomalidomide in combination with dexamethasone.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/17/2025

Locations: Duplicate_University of Arizona Cancer Center - North Campus /ID# 218407, Tucson, Arizona +179 locations

Duplicate_University of Arizona Cancer Center - North Campus /ID# 218407, Tucson, Arizona

VA Central California Health Care System /ID# 200047, Fresno, California

University of California, Los Angeles /ID# 171524, Los Angeles, California

Rocky Mountain Regional VA Medical Center/Eastern Colorado Health Care System /ID# 222904, Aurora, Colorado

Mayo Clinic /ID# 200075, Jacksonville, Florida

Cleveland Clinic Florida /ID# 208884, Weston, Florida

Duplicate_Norton Cancer Institute /ID# 200834, Louisville, Kentucky

University of Maryland, Baltimore /ID# 217422, Baltimore, Maryland

Boston Medical Center /ID# 223606, Boston, Massachusetts

Barbara Ann Karmanos Cancer In /ID# 201377, Detroit, Michigan

Duplicate_Henry Ford Hospital /ID# 171531, Detroit, Michigan

Mayo Clinic - Rochester /ID# 201091, Rochester, Minnesota

Columbia University Medical Center /ID# 200715, New York, New York

Fairview Hospital - Moll Pavilion /ID# 208919, Cleveland, Ohio

Cleveland Clinic Main Campus /ID# 202247, Cleveland, Ohio

UPMC Hillman Cancer Ctr /ID# 200063, Pittsburgh, Pennsylvania

MD Anderson Cancer Center at Texas Medical Center /ID# 200060, Houston, Texas

Huntsman Cancer Institute /ID# 218406, Salt Lake City, Utah

VA Puget Sound Health Care System /ID# 222708, Seattle, Washington

Liverpool Hospital /ID# 202431, Liverpool, New South Wales

Sydney Adventist Hospital /ID# 222874, Wahroonga, New South Wales

Wollongong Hospital /ID# 205545, Wollongong, New South Wales

ICON Cancer Care - Townsville /ID# 206565, Hyde Park, Queensland

Icon Cancer Centre /ID# 205663, South Brisbane, Queensland

The Queen Elizabeth Hospital /ID# 202432, Woodville South, South Australia

Perth Blood Institute Ltd /ID# 206649, Nedlands, Western Australia

Arthur J. E. Child Comprehensive Cancer Centre /ID# 218846, Calgary, Alberta

BC Cancer - Vancouver /ID# 222804, Vancouver, British Columbia

Queen Elizabeth II Health Sciences Centre - Victoria General /ID# 218883, Halifax, Nova Scotia

CISSS-CA (Centre Integre de sante et de services sociaux de Chaudiere-Appalache) /ID# 218887, Levis, Quebec

Beijing Chaoyang Hospital,Capital Medical University /ID# 216014, Beijing, Beijing

Peking University Third Hospital /ID# 216371, Beijing, Beijing

Peking Union Medical College Hospital (East) - Dongdan Campus /ID# 216040, Beijing, Beijing

Sun Yat-Sen University Cancer Center /ID# 223828, Guangzhou, Guangdong

Guangdong Provincial People's Hospital /ID# 215860, Guangzhou, Guangdong

Henan Cancer Hospital /ID# 215987, Zhengzhou, Henan

Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 215850, Wuhan, Hubei

Nanjing Drum Tower Hospital /ID# 223143, Nanjing, Jiangsu

The First Affiliated Hospital of Soochow University /ID# 216094, Suzhou, Jiangsu

The First Affiliated Hospital of Nanchang University /ID# 216954, Nanchang, Jiangxi

The First Hospital of China Medical University /ID# 215996, Shenyang, Liaoning

Shengjing Hospital of China Medical University /ID# 223435, Shenyang, Liaoning

Ruijin Hospital, Shanghai Jiaotong University School of Medicine /ID# 216643, Shanghai, Shanghai

Shanghai Tongji Hospital /ID# 218865, Shanghai, Shanghai

West China Hospital, Sichuan University /ID# 216647, Chengdu, Sichuan

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc /ID# 216041, Tianjin, Tianjin

Tianjin Medical University Cancer Institute & Hospital /ID# 223550, Tianjin, Tianjin

The First Affiliated Hospital, Zhejiang University School of Medicine /ID# 215989, Hangzhou, Zhejiang

The First Affiliated Hospital, Zhejiang University School of Medicine /ID# 218691, Hangzhou, Zhejiang

The First Affiliated Hospital of Wenzhou Medical University /ID# 218953, Wenzhou, Zhejiang

Beijing Chaoyang Hospital, Capital Medical University(West campus) /ID# 234033, Beijing, Not set

Fakultní Nemocnice Brno - Jihlavská /ID# 204512, Brno, Brno-mesto

Fakultní nemocnice Hradec Králové - Sokolská /ID# 221291, Hradec Králové, Hradec Kralove

Fakultni Nemocnice Ostrava /ID# 204515, Ostrava, Ostrava-mesto

Fakultni nemocnice Olomouc /ID# 221290, Olomouc, Not set

Vseobecna fakultni nemocnice v Praze /ID# 221166, Praha, Not set

Duplicate_Herlev Hospital /ID# 223221, Herlev, Hovedstaden

Aalborg University Hospital /ID# 223220, Aalborg, Nordjylland

Odense University Hospital /ID# 223217, Odense, Syddanmark

Sygehus Lillebalt, Vejle /ID# 223216, Vejle, Syddanmark

Duplicate_Roskilde Hospital /ID# 223366, Roskilde, Not set

Hopital Pitie Salpetriere /ID# 214173, Paris Cedex 13, Ile-de-France

Duplicate_CHU Grenoble - Hopital Michallon /ID# 223182, La Tronche, Isere

CHU Reims - Hôpital Robert Debre /ID# 233907, Reims CEDEX, Marne

CHRU Nancy - Hopitaux de Brabois /ID# 201076, Vandoeuvre-les-Nancy, Meurthe-et-Moselle

CHRU Lille - Hopital Claude Huriez /ID# 202213, Lille, Nord

Hopitaux Universitaires Henri Mondor - Hopital Henri Mondor /ID# 202211, Creteil, Paris

CHU de Nantes, Hotel Dieu -HME /ID# 200099, Nantes, Pays-de-la-Loire

HCL - Hopital Lyon Sud /ID# 200097, Pierre Benite CEDEX, Rhone

Centre Henri Becquerel /ID# 223186, Rouen, Seine-Maritime

CH Henri Duffaut /ID# 234154, Avignon CEDEX 9, Vaucluse

Robert-Bosch-Krankenhaus /ID# 223947, Stuttgart, Baden-Wuerttemberg

Universitaetsklinikum Tuebingen /ID# 238646, Tubingen, Baden-Wuerttemberg

Universitaetsklinikum Wuerzburg /ID# 200055, Wuerzburg, Bayern

Klinikum Chemnitz gGmbH /ID# 233797, Chemnitz, Sachsen

Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 201830, Kiel, Schleswig-Holstein

Universitaetsklinikum Jena /ID# 201254, Jena, Thueringen

Charite Universitaetsklinikum Berlin - Campus Benjamin Franklin /ID# 200051, Berlin, Not set

Universitaetsklinikum Hamburg-Eppendorf /ID# 215495, Hamburg, Not set

Asklepios Klinik Altona /ID# 222506, Hamburg, Not set

Alexandra General Hospital /ID# 202386, Athens, Attiki

University General Hospital of Heraklion PA.G.N.I /ID# 222879, Heraklion, Kriti

General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 213982, Athens, Not set

University Gen Hosp of Patra /ID# 201691, Patras, Not set

Theageneio Anticancer Hospital /ID# 213983, Thessaloniki, Not set

General Hospital of Thessaloniki George Papanikolaou /ID# 201692, Thessaloniki, Not set

Rambam Health Care Campus /ID# 169678, Haifa, H_efa

Bnai Zion Medical Center /ID# 169466, Haifa, H_efa

The Lady Davis Carmel Medical Center /ID# 222969, Haifa, H_efa

Duplicate_Assuta Ashdod Medical Center /ID# 222968, Ashdod, HaDarom

Soroka University Medical Center /ID# 218768, Be'er Sheva, HaDarom

The Chaim Sheba Medical Center /ID# 169778, Ramat Gan, Tel-Aviv

Tel Aviv Sourasky Medical Center /ID# 169437, Tel Aviv, Tel-Aviv

Hadassah /ID# 169474, Jerusalem, Yerushalayim

Rabin Medical Center /ID# 244611, Petah Tikva, Not set

Duplicate_IRCCS AOU di Bologna - Policlinico Sant'Orsola-Malpighi /ID# 170952, Bologna, Emilia-Romagna

A.O.U. CITTA' DELLA SALUTE E DELLA SCIENZA DI TORINO - Ospedale Molinette /ID# 170962, Torino, Piemonte

Irccs-Crob /Id# 170955, Rionero In Vulture, Potenza

Azienda Ospedaliero Universitaria delle Marche /ID# 170950, Ancona, Not set

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico /ID# 212498, Milano, Not set

Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello /ID# 222988, Palermo, Not set

Azienda Ospedaliera Santa Maria Terni /ID# 170948, Terni, Not set

Nagoya City University Hospital /ID# 170880, Nagoya shi, Aichi

The Jikei University Kashiwa Hospital /ID# 223031, Kashiwa-shi, Chiba

Kyushu University Hospital /ID# 171117, Fukuoka-shi, Fukuoka

Ogaki Municipal Hospital /ID# 171043, Ogaki-shi, Gifu

Gunma University Hospital /ID# 170966, Maebashi-shi, Gunma

Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital /ID# 171255, Hiroshima-shi, Hiroshima

Kobe City Medical Center General Hospital /ID# 170992, Kobe-shi, Hyogo

Duplicate_National Hospital Organization Mito Medical Center /ID# 171187, Higashi Ibaraki-gun, Ibaraki

Hitachi General Hospital /ID# 200843, Hitachi-shi, Ibaraki

Iwate Medical University Hospital /ID# 222849, Shiwa-gun, Iwate

Tohoku University Hospital /ID# 201935, Sendai-shi, Miyagi

Okayama Medical Center /ID# 200119, Okayama-shi, Okayama

Japanese Red Cross Osaka Hospital /ID# 171493, Osaka-shi, Osaka

The University of Osaka Hospital /ID# 201966, Suita-shi, Osaka

Tokushima University Hospital /ID# 202571, Tokushima-shi, Tokushima

The Jikei University Hospital /ID# 239014, Minato-ku, Tokyo

Japanese Red Cross Medical Center /ID# 171256, Shibuya-ku, Tokyo

Yamagata University Hospital /ID# 238329, Yamagata-shi, Yamagata

Duplicate_Gachon University Gil Medical Center /ID# 202827, Incheon, Gyeonggido

Seoul National University Hospital /ID# 202711, Seoul, Seoul Teugbyeolsi

Samsung Medical Center /ID# 202710, Seoul, Seoul Teugbyeolsi

The Catholic University of Korea, Seoul St. Marys Hospital /ID# 234045, Seoul, Seoul Teugbyeolsi

Ulsan University Hospital /ID# 222716, Ulsan, Ulsan Gwang Yeogsi

Yonsei University Health System Severance Hospital /ID# 202709, Seoul, Not set

Moscow State budget healthcare /ID# 169685, Moscow, Moskva

Research Institute of Fundamental and Clinical Immunology /ID# 223594, Novosibirsk, Novosibirskaya Oblast

LLC Novaya Klinika /ID# 169689, Pyatigorsk, Stavropol Skiy Kray

City Clinical Hospital #52 /ID# 206289, Moscow, Not set

Leningrad Regional Clinical Hospital /ID# 202776, Saint Petersburg, Not set

Almazov National Medical Research Centre /ID# 169681, Sankt-Peterburg, Not set

Tula Regional Clinical Hospital /ID# 223226, Tula, Not set

National University Hospital /ID# 203988, Singapore, Not set

Singapore General Hospital /ID# 202131, Singapore, Not set

Tan Tock Seng Hospital /ID# 204374, Singapore, Not set

Hospital Universitari Son Espases /ID# 222889, Palma de Mallorca, Illes Balears

Hospital Costa del Sol /ID# 234083, Marbella, Malaga

Complejo Hospitalario Universitario Ourense /ID# 222876, Orense, Ourense

Hospital Universitario Canarias /ID# 238452, San Cristóbal de La Laguna, Santa Cruz De Tenerife

Hospital Universitario Vall d'Hebron /ID# 218106, Barcelona, Not set

Instituto Catalan de Oncologia (ICO) Girona /ID# 171311, Girona, Not set

Hospital de Leon /ID# 233878, Leon, Not set

Hospital Universitario Fundacion Jimenez Diaz /ID# 171304, Madrid, Not set

Disc_Hospital Universitario 12 de Octubre /ID# 171288, Madrid, Not set

Hospital Universitario La Paz /ID# 218107, Madrid, Not set

Hospital Universitario de Salamanca /ID# 171294, Salamanca, Not set

Hospital Universitario Virgen del Rocio /ID# 171286, Sevilla, Not set

Hospital General Universitario de Toledo /ID# 222887, Toledo, Not set

Hospital Universitario y Politecnico La Fe /ID# 234019, Valencia, Not set

Sunderby sjukhus /ID# 201314, Lulea, Norrbottens Lan

Sodra Alvsborgs sjukhus /ID# 213061, Boras, Vastra Gotalands Lan

Duplicate_Universitetssjukhuset Linköping /ID# 200789, Linkoping, Vastra Gotalands Lan

Uddevalla sjukhus /ID# 201315, Uddevalla, Vastra Gotalands Lan

Cukurova Universitesi Tip Fakultesi /ID# 201955, Saricam Adana, Adana

Izmir Ekonomi Universitesi Ozel Medicalpoint Hastanesi /ID# 201954, Karsiyaka, Izmir

Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi /ID# 201956, Ankara, Not set

Gazi University Medical Faculty /ID# 222698, Ankara, Not set

Ankara Univ Medical Faculty /ID# 201881, Ankara, Not set

Istanbul University Istanbul Medical Faculty /ID# 201953, Istanbul, Not set

Bagcilar Medipol Mega Universite Hastanesi /ID# 222914, Istanbul, Not set

Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi /ID# 201952, Istanbul, Not set

Ege University Medical Faculty /ID# 222697, Izmir, Not set

Communal Nonprofit Enterprise Cherkasy Regional Oncology Dispensary /ID# 223943, Cherkasy, Cherkaska Oblast

Communal non-profit enterprise Regional Center of Oncology /ID# 223945, Kharkiv, Kharkivska Oblast

MNI Khmelnytskyi Regional Hospital of Khmelnytskyi Regional Council /ID# 223942, Khmelnytskyi, Not set

National Cancer Institute /ID# 223944, Kyiv, Not set

SI Institute of Blood Pathology and Transfusion Medicine of NAMS of Ukraine /ID# 223941, Lviv, Not set

Addenbrooke's Hospital /ID# 223097, Cambridge, Cambridgeshire

Hammersmith Hospital /ID# 171446, London, England

University College London Hospital /ID# 171428, London, Greater London

Norfolk and Norwich University Hospitals NHS Foundation Trust /ID# 218213, Norwich, Norfolk

Duplicate_Nottingham University Hospitals NHS Trust /ID# 223292, Nottingham, Nottinghamshire

Duplicate_NHS Greater Glasgow and Clyde /ID# 202199, Glasgow, Scotland

Duplicate_University Hospitals North Midlands - Royal Stoke University Hospital /ID# 218355, Stoke-on-Trent, Staffordshire

Duplicate_Duplicate_Lewisham and Greenwich NHS Trust /ID# 171445, London, Not set

Manchester University NHS Foundation Trust /ID# 171440, Manchester, Not set

Portsmouth Hospitals University NHS Trust /ID# 171444, Portsmouth, Not set

Royal Berkshire NHS Foundation Trust /ID# 217835, Reading, Not set

Duplicate_Sheffield Teaching Hospitals NHS Foundation Trust - Royal Hallamshire /ID# 171447, Sheffield, Not set

Conditions: Multiple Myeloma

Learn More ›

Trial of Combination of Ixazomib and Lenalidomide and Dexamethasone in Smoldering Multiple Myeloma

NCT02916771

Completed

This research study is evaluating a new drug called "ixazomib" as a possible treatment for Smoldering Multiple Myeloma.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/17/2025

Locations: Dana Farber Cancer Institute, Boston, Massachusetts

Conditions: Smoldering Multiple Myeloma

Learn More ›

Phase I Study of Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma

NCT07032714

Not Yet Recruiting

This is a phase 1 study to find the recommended dose and schedule of mezigdomide and talquetamab in relapsed and refractory multiple myeloma (RRMM), and to test the effects of the drugs on cancer. Cohort A will receive talquetamab + dexamethasone, then mezigdomide + talquetamab,+ dexamethasone. After Cohort A, Cohort B will evaluate mezigdomide + dexamethasone followed by step-up dosing of talquetamab (mezigdomide + talquetamab,+ dexamethasone).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/16/2025

Locations: Massachusetts General Hospital, Boston, Massachusetts +2 locations

Conditions: Relapsed Refractory Multiple Myeloma (RRMM)

Learn More ›

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

NCT04973605

Recruiting

The purpose of this study is to assess the safety, tolerability, and efficacy of sonrotoclax as monotherapy and in various combinations in patients with relapsed/refractory (R/R) multiple myeloma (MM) and chromosomal translocation t(11;14). The study investigates sonrotoclax alone and in combination with dexamethasone and other agents, including carfilzomib, daratumumab, and pomalidomide.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/16/2025

Locations: University of Alabama At Birmingham Hospital, Birmingham, Alabama +87 locations

University of Alabama At Birmingham Hospital, Birmingham, Alabama

City of Hope National Medical Center, Duarte, California

City of Hope At Irvine Lennar, Irvine, California

University of California At San Francisco, San Francisco, California

University of Miami, Miami, Florida

Emory University Winship Cancer Center, Atlanta, Georgia

University of Chicago Medical Center, Chicago, Illinois

Southern Illinois University School of Medicine, Springfield, Illinois

Massachusetts General Hospital, Boston, Massachusetts

Washington University School of Medicine, Saint Louis, Missouri

Hackensack University Medical Center, Hackensack, New Jersey

Weill Cornell Medical College Newyork Presbyterian Hospital, New York, New York

Memorial Sloan Kettering Cancer Center Mskcc, New York, New York

The James Cancer Hospital and Solove Research Institute At Ohio State University, Columbus, Ohio

Huntsman Cancer Institute, Salt Lake City, Utah

University of Washington, Seattle, Washington

University of Wisconsin Carbone Cancer Center, Madison, Wisconsin

Medical College of Wisconsin, Milwaukee, Wisconsin

Canberra Hospital, Garran, Australian Capital Territory

Nepean Hospital, Kingswood, New South Wales

Monash Health, Clayton, Victoria

St Vincents Hospital Melbourne, Fitzroy, Victoria

The Alfred Hospital, Melbourne, Victoria

Royal Perth Hospital, Perth, Western Australia

Hospital Sirio Libanes Brasilia, Brasilia, Not set

Instituto Dor de Pesquisa E Ensino Distrito Federal, Brasilia, Not set

Centro Gaucho Integrado de Oncologia Hospital Mae de Deus, Porto Alegre, Not set

Hospital Sao Rafael (Rede Dor), Salvador, Not set

Hospital Sirio Libanes, Sao Paulo, Not set

Hospital Nove de Julho Dasa, Sao Paulo, Not set

Accamargo Cancer Center, Sao Paulo, Not set

Instituto Dor de Pesquisa E Ensino Sao Paulo, Sao Paulo, Not set

Clinica Sao Germano, Sao Paulo, Not set

Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein, Sao Paulo, Not set

Cross Cancer Institute, Edmonton, Alberta

British Columbia Cancer Agency the Vancouver Centre, Vancouver, British Columbia

Princess Margaret Cancer Centre, Toronto, Ontario

Beijing Chao Yang Hospital, Beijing, Beijing

Peking University Peoples Hospital, Beijing, Beijing

Chongqing Cancer Hospital, Chongqing, Chongqing

Fujian Medical University Union Hospital, Fuzhou, Fujian

The First Affiliated Hospital of Xiamen University, Xiamen, Fujian

Sun Yat Sen University Cancer Center, Guangzhou, Guangdong

The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei

Henan Cancer Hospital, Zhengzhou, Henan

The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan

Hunan Cancer Hospital, Changsha, Hunan

Jiangsu Province Hospital, Nanjing, Jiangsu

The First Affiliated Hospital of Nanchang University Branch Xianghu, Nanchang, Jiangxi

The First Hospital of China Medical University, Shenyang, Liaoning

Qingdao Municipal Hospital, Qingdao, Shandong

Affiliated Zhongshan Hospital of Fudan University, Shanghai, Shanghai

Shanghai Fourth Peoples Hospital Affiliated to Tongji University, Shanghai, Shanghai

Tianjin Medical University General Hospital, Tianjin, Tianjin

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang

Hopital Claude Huriez Chu Lille, Lille, Not set

Centre Hospitalier Universitaire Nantes Hotel Dieu, Nantes, Not set

Chu de Poitiers Site de La Mileterie, Poitiers, Not set

Universitaetsklinikum Aachen, Aachen, Not set

Universitatsklinikum Carl Gustav Carus An Der Technischen Universitat Dresden, Dresden, Not set

Universitatsklinikum Hamburg Eppendorf, Hamburg, Not set

Universitatsklinikum Wurzburg, Wurzburg, Not set

University Hospital of Alexandroupolis, Alexandroupolis, Not set

General Hospital of Athens Alexandra, Athens, Not set

Sourasky Medical Center, Jaffa, Not set

Rabin Medical Center, Petach Tikva, Not set

Azienda Ospedaliera Policlinico Di Bari, Bari, Not set

Policlinico Sorsola Malpighi, Aou Di Bologna, Bologna, Not set

Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori Irst, Meldola, Not set

Istituto Europeo Di Oncologia, Milano, Not set

Fondazione Policlinico Universitario Agostino Gemelli, Roma, Not set

Istituto Di Candiolo Irccs, Torino, Not set

Azienda Ospedaliera Universitaria Delle Marche, Torrette, Not set

Samsung Medical Center, GangnamGu, Seoul Teugbyeolsi

The Catholic University of Korea, Seoul St Marys Hospital, SeochoGu, Seoul Teugbyeolsi

Severance Hospital Yonsei University Health System, SeodaemunGu, Seoul Teugbyeolsi

Seoul National University Hospital, Seoul, Seoul Teugbyeolsi

Asan Medical Center, SongpaGu, Seoul Teugbyeolsi

Aotearoa Clinical Trials, Auckland, Not set

National University Hospital Singapore, Singapore, Not set

Hospital Clinic de Barcelona, Barcelona, Not set

Hospital San Pedro de Alcantara, Caceres, Not set

Hospital Universitario Virgen de La Victoria, Malaga, Not set

Hospital Universitario Virgen Del Rocio, Sevilla, Not set

Churchill Hospital Oxford University Hospital Nhs Trust, Headington, Not set

University College Hospital, London, Not set

Royal Marsden Nhs Foundation Royal Marsden Hospital, Sutton, Not set

Royal Cornwall Hospitalsnhs Trust, Truro, Not set

Conditions: Relapsed/Refractory Multiple Myeloma

Learn More ›

Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation

NCT06348147

Suspended

This Phase II hybrid decentralized trial will examine the effect of daratumumab-based quadruplet induction therapy administered at an attenuated schedule in subjects with newly diagnosed multiple myeloma (NDMM) who are eligible for standard-of-care autologous stem cell transplantation (ASCT). Daratumumab, lenalidomide, bortezomib, and dexamethasone (Dara-RVd) have recently become a standard induction regimen for patients with NDMM who are eligible for ASCT in the United States. As implemented in... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/16/2025

Locations: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina

Conditions: Newly Diagnosed Multiple Myeloma, Multiple Myeloma, Autologous Stem Cell Transplantation

Learn More ›

Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM)

NCT06087653

Recruiting

Primary Objective • Assess the safety and tolerability of low-dose lenalidomide administered by continuous subcutaneous (SC) infusion (STAR-LLD) in combination with dexamethasone and a proteasome inhibitor (PI). Secondary Objectives * • To establish the pharmacokinetic (PK) profile of STAR-LLD at a defined infusion rate targeting steady-state blood concentrations. * • Evaluate changes in efficacy indicators including objective response rate (ORR), progression-free survival (PFS), and duration... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/16/2025

Locations: Regional Oncology Center, Wilson, North Carolina +1 locations

Conditions: Multiple Myeloma

Learn More ›

Browse by State

Dexamethasone treatment options in Alabama

Dexamethasone treatment options in Alaska

Dexamethasone treatment options in Arizona

Dexamethasone treatment options in Arkansas

Dexamethasone treatment options in California

Dexamethasone treatment options in Colorado

Dexamethasone treatment options in Connecticut

Dexamethasone treatment options in Delaware

Dexamethasone treatment options in District of Columbia

Dexamethasone treatment options in Florida

Dexamethasone treatment options in Georgia

Dexamethasone treatment options in Hawaii

Dexamethasone treatment options in Idaho

Dexamethasone treatment options in Illinois

Dexamethasone treatment options in Indiana

Dexamethasone treatment options in Iowa

Dexamethasone treatment options in Kansas

Dexamethasone treatment options in Kentucky

Dexamethasone treatment options in Louisiana

Dexamethasone treatment options in Maine

Dexamethasone treatment options in Montana

Dexamethasone treatment options in Nebraska

Dexamethasone treatment options in Nevada

Dexamethasone treatment options in New Hampshire

Dexamethasone treatment options in New Jersey

Dexamethasone treatment options in New Mexico

Dexamethasone treatment options in New York

Dexamethasone treatment options in North Carolina

Dexamethasone treatment options in North Dakota

Dexamethasone treatment options in Ohio

Dexamethasone treatment options in Oklahoma

Dexamethasone treatment options in Oregon

Dexamethasone treatment options in Maryland

Dexamethasone treatment options in Massachusetts

Dexamethasone treatment options in Michigan

Dexamethasone treatment options in Minnesota

Dexamethasone treatment options in Mississippi

Dexamethasone treatment options in Missouri

Dexamethasone treatment options in Pennsylvania

Dexamethasone treatment options in Rhode Island

Dexamethasone treatment options in South Carolina

Dexamethasone treatment options in South Dakota

Dexamethasone treatment options in Tennessee

Dexamethasone treatment options in Texas

Dexamethasone treatment options in Utah

Dexamethasone treatment options in Vermont

Dexamethasone treatment options in Virginia

Dexamethasone treatment options in Washington

Dexamethasone treatment options in West Virginia

Dexamethasone treatment options in Wisconsin

Dexamethasone treatment options in Wyoming